Name | Number of supported studies  | Average coverage | |
|---|---|---|---|
| oligodendrocyte | 15 studies | 46% ± 19% | |
| type I pneumocyte | 10 studies | 38% ± 14% | |
| oligodendrocyte precursor cell | 10 studies | 47% ± 21% | |
| endothelial cell | 7 studies | 25% ± 13% | |
| endothelial cell of artery | 7 studies | 35% ± 10% | |
| mesothelial cell | 5 studies | 33% ± 12% | |
| renal alpha-intercalated cell | 4 studies | 44% ± 7% | |
| capillary endothelial cell | 4 studies | 26% ± 5% | |
| basal cell | 3 studies | 25% ± 10% | |
| epithelial cell | 3 studies | 55% ± 16% |
Name | Number of supported studies | Average coverage | |
|---|---|---|---|
| brain | 6 studies | 28% ± 16% |
Tissue | GTEx Coverage | GTEx Average TPM | GTEx Number of samples | TCGA Coverage | TCGA Average TPM | TCGA Number of samples |
|---|---|---|---|---|---|---|
| brain | 98% | 5542.74 | 2598 / 2642 | 99% | 23.35 | 697 / 705 |
| kidney | 99% | 2641.00 | 88 / 89 | 94% | 17.42 | 846 / 901 |
| pancreas | 93% | 2096.45 | 305 / 328 | 92% | 19.27 | 164 / 178 |
| lung | 98% | 3945.59 | 568 / 578 | 83% | 9.83 | 962 / 1155 |
| thymus | 84% | 1034.80 | 549 / 653 | 84% | 5.26 | 511 / 605 |
| stomach | 81% | 4036.84 | 292 / 359 | 73% | 10.83 | 210 / 286 |
| esophagus | 53% | 976.83 | 767 / 1445 | 76% | 10.34 | 139 / 183 |
| bladder | 38% | 491.48 | 8 / 21 | 66% | 6.44 | 333 / 504 |
| prostate | 67% | 935.60 | 165 / 245 | 36% | 1.69 | 181 / 502 |
| intestine | 28% | 497.33 | 275 / 966 | 72% | 8.58 | 382 / 527 |
| ureter | 0% | 0 | 0 / 0 | 100% | 26.71 | 1 / 1 |
| ovary | 3% | 29.96 | 6 / 180 | 93% | 11.58 | 402 / 430 |
| breast | 47% | 622.02 | 218 / 459 | 48% | 2.97 | 536 / 1118 |
| spleen | 93% | 1537.08 | 224 / 241 | 0% | 0 | 0 / 0 |
| skin | 72% | 4639.47 | 1302 / 1809 | 17% | 0.76 | 78 / 472 |
| uterus | 20% | 225.99 | 34 / 170 | 68% | 7.77 | 312 / 459 |
| tonsil | 0% | 0 | 0 / 0 | 73% | 4.30 | 33 / 45 |
| liver | 10% | 87.89 | 22 / 226 | 47% | 5.62 | 191 / 406 |
| adipose | 40% | 590.07 | 481 / 1204 | 0% | 0 | 0 / 0 |
| adrenal gland | 1% | 9.47 | 3 / 258 | 31% | 2.14 | 71 / 230 |
| heart | 11% | 116.61 | 98 / 861 | 0% | 0 | 0 / 0 |
| blood vessel | 8% | 107.88 | 107 / 1335 | 0% | 0 | 0 / 0 |
| lymph node | 0% | 0 | 0 / 0 | 7% | 0.24 | 2 / 29 |
| eye | 0% | 0 | 0 / 0 | 6% | 0.22 | 5 / 80 |
| muscle | 0% | 3.25 | 3 / 803 | 0% | 0 | 0 / 0 |
| abdomen | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| bone marrow | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| diaphragm | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| gingiva | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| nasal cavity | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| nasopharynx | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| nose | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| peripheral blood | 0% | 0 | 0 / 929 | 0% | 0 | 0 / 0 |
| placenta | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| spinal column | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| GO_0034220 | Biological process | monoatomic ion transmembrane transport |
| GO_0042552 | Biological process | myelination |
| GO_0043218 | Cellular component | compact myelin |
| GO_0016020 | Cellular component | membrane |
| GO_0005515 | Molecular function | protein binding |
| GO_0019911 | Molecular function | structural constituent of myelin sheath |
| Gene name | PLLP |
| Protein name | Plasmolipin Plasmolipin (Plasma membrane proteolipid) |
| Synonyms | PMLP TM4SF11 |
| Description | FUNCTION: Appears to be involved in myelination. Could also participate in ion transport events as addition of plasmolipin to lipid bilayers induces the formation of ion channels, which are voltage-dependent and K(+)-selective (By similarity). . |
| Accessions | Q9Y342 A0A087WYE0 J3QLJ3 ENST00000219207.10 ENST00000564018.1 H3BN27 ENST00000613167.4 ENST00000569059.5 |
